Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 1
2016 6
2017 5
2018 1
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial.
Martinelli E, Martini G, Famiglietti V, Troiani T, Napolitano S, Pietrantonio F, Ciardiello D, Terminiello M, Borrelli C, Vitiello PP, De Braud F, Morano F, Avallone A, Normanno N, Nappi A, Maiello E, Latiano T, Falcone A, Cremolini C, Rossini D, Santabarbara G, Pinto C, Santini D, Cardone C, Zanaletti N, Di Liello A, Renato D, Esposito L, Marrone F, Ciardiello F. Martinelli E, et al. Among authors: santabarbara g. JAMA Oncol. 2021 Oct 1;7(10):1529-1535. doi: 10.1001/jamaoncol.2021.2915. JAMA Oncol. 2021. PMID: 34382998 Free PMC article. Clinical Trial.
Overcoming Resistance to EGFR Inhibitors in NSCLC.
Maione P, Sacco PC, Casaluce F, Sgambato A, Santabarbara G, Rossi A, Gridelli C. Maione P, et al. Among authors: santabarbara g. Rev Recent Clin Trials. 2016;11(2):99-105. doi: 10.2174/1574887111666160330120431. Rev Recent Clin Trials. 2016. PMID: 27028971 Review.
Selumetinib for the treatment of non-small cell lung cancer.
Casaluce F, Sgambato A, Maione P, Sacco PC, Santabarbara G, Gridelli C. Casaluce F, et al. Among authors: santabarbara g. Expert Opin Investig Drugs. 2017 Aug;26(8):973-984. doi: 10.1080/13543784.2017.1351543. Epub 2017 Jul 12. Expert Opin Investig Drugs. 2017. PMID: 28675058 Review.
The safety of second-line treatment options for non-small cell lung cancer.
Rossi A, Maione P, Santabarbara G, Sacco PC, Casaluce F, Sgambato A, Barzelloni ML, Palazzolo G, Gridelli C. Rossi A, et al. Among authors: santabarbara g. Expert Opin Drug Saf. 2017 Apr;16(4):471-479. doi: 10.1080/14740338.2017.1297795. Epub 2017 Mar 1. Expert Opin Drug Saf. 2017. PMID: 28276858 Review.
Optimal drugs for second-line treatment of patients with small-cell lung cancer.
Rossi A, Sacco PC, Sgambato A, Casaluce F, Santabarbara G, Palazzolo G, Maione P, Gridelli C. Rossi A, et al. Among authors: santabarbara g. Expert Opin Pharmacother. 2016;17(7):969-76. doi: 10.1517/14656566.2016.1154539. Epub 2016 Feb 29. Expert Opin Pharmacother. 2016. PMID: 26878692 Review.
Current status of targeted therapies in advanced gastric cancer.
De Vita F, Giuliani F, Silvestris N, Rossetti S, Pizzolorusso A, Santabarbara G, Galizia G, Colucci G, Ciardiello F, Orditura M. De Vita F, et al. Among authors: santabarbara g. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S29-34. doi: 10.1517/14728222.2011.652616. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22443228 Review.
New approach to implement cancer patient care: The valutazione percorso rete oncologica campana (ValPeROC)-experience from an Italian oncology network.
Crispo A, Rivieccio G, Cataldo L, Coluccia S, Luongo A, Coppola E, Grimaldi M, Montagnese C, Nocerino F, D'Errico D, Celentano E, Saviano R, Bastone A, Baglio G, De Angelis C, Ciardiello F, Avallone A, Cassata A, Costanzo R, Morabito A, Maione P, Gridelli C, Cigolari S, Borrelli A, De Placido S, Schiavone F, Bianchi AAM, Pignata S; ValPeROC Group. Crispo A, et al. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13736. doi: 10.1111/ecc.13736. Epub 2022 Oct 25. Eur J Cancer Care (Engl). 2022. PMID: 37039607
Developments in pharmacotherapy for treating metastatic non-small cell lung cancer.
Rossi A, Sacco PC, Santabarbara G, Sgambato A, Casaluce F, Palazzolo G, Maione P, Gridelli C. Rossi A, et al. Among authors: santabarbara g. Expert Opin Pharmacother. 2017 Feb;18(2):151-163. doi: 10.1080/14656566.2017.1280460. Epub 2017 Jan 20. Expert Opin Pharmacother. 2017. PMID: 28067062 Review.
16 results